127 related articles for article (PubMed ID: 9723570)
21. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF).
Kaleelrahman M; Eaton JD; Leeming D; Bowyer K; Taberner D; Chang J; Scarffe JH; Chopra R
Hematology; 2003 Apr; 8(2):91-5. PubMed ID: 12745658
[TBL] [Abstract][Full Text] [Related]
22. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation.
Salat C; Holler E; Kolb HJ; Reinhardt B; Pihusch R; Wilmanns W; Hiller E
Blood; 1997 Mar; 89(6):2184-8. PubMed ID: 9058743
[TBL] [Abstract][Full Text] [Related]
23. Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease.
Salat C; Holler E; Reinhardt B; Kolb HJ; Seeber B; Ledderose G; Mittermueller J; Duell T; Wilmanns W; Hiller E
Bone Marrow Transplant; 1994 Nov; 14(5):747-50. PubMed ID: 7889007
[TBL] [Abstract][Full Text] [Related]
24. Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications.
Nürnberger W; Michelmann I; Burdach S; Göbel U
Ann Hematol; 1998 Feb; 76(2):61-5. PubMed ID: 9540759
[TBL] [Abstract][Full Text] [Related]
25. Association of Helicobacter pylori with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome after bone marrow transplantation.
Takatsuka H; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H; Kakishita E
Clin Transplant; 2004 Oct; 18(5):547-51. PubMed ID: 15344958
[TBL] [Abstract][Full Text] [Related]
26. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
Lee JH; Lee KH; Choi SJ; Min YJ; Kim JG; Kim S; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
Bone Marrow Transplant; 2000 Sep; 26(6):657-62. PubMed ID: 11041568
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.
Sarode R; McFarland JG; Flomenberg N; Casper JT; Cohen EP; Drobyski WR; Ash RC; Horowitz MM; Camitta B; Lawton C
Bone Marrow Transplant; 1995 Aug; 16(2):271-5. PubMed ID: 7581147
[TBL] [Abstract][Full Text] [Related]
28. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T
Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
[TBL] [Abstract][Full Text] [Related]
29. Hemostatic abnormalities following bone marrow transplantation.
Tamaki S; Wada H; Ohfuzi K; Shibata T; Masuya M; Kageyama S; Gabazza EC; Kawakami K; Tsuji K; Miyanishi E; Minami N; Nobori T; Shiku H
Clin Appl Thromb Hemost; 2002 Apr; 8(2):125-32. PubMed ID: 12121052
[TBL] [Abstract][Full Text] [Related]
30. [A study on the significance of plasma thrombospondin1 in thrombotic thrombocytopenic purpura and the relationship between thrombospondin1 and von Willebrand factor cleaving protease (ADAMTS13)].
Liu F; Lu GY; Dong NZ; Bai X; Su J; Ruan CG
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3190-3. PubMed ID: 16405838
[TBL] [Abstract][Full Text] [Related]
31. A case of thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation.
Tschuchnigg M; Bradstock KF; Koutts J; Stewart J; Enno A; Seldon M
Bone Marrow Transplant; 1990 Jan; 5(1):61-3. PubMed ID: 2297591
[TBL] [Abstract][Full Text] [Related]
32. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation.
Takatsuka H; Wakae T; Mori A; Okada M; Suehiro A; Okamoto T; Kakishita E
Bone Marrow Transplant; 2002 Jun; 29(11):907-11. PubMed ID: 12080356
[TBL] [Abstract][Full Text] [Related]
33. Microangiopathic hemolytic anemia and renal impairment following autologous bone marrow transplantation: a case of hemolytic uremic syndrome?
Wassmann B; Martin H; Elsner S; Bruecher J; Thaiss F; Stahl RA; Hoelzer D
Bone Marrow Transplant; 1994 Nov; 14(5):849-51. PubMed ID: 7889019
[TBL] [Abstract][Full Text] [Related]
34. Fatal chronic relapsing thrombotic thrombocytopenic purpura following autologous bone marrow transplantation for chronic myeloid leukemia.
Lugassy G; Ducach A; Blumenthal R
Bone Marrow Transplant; 1998 Apr; 21(8):859-60. PubMed ID: 9603418
[TBL] [Abstract][Full Text] [Related]
35. The role of plasma exchange for TTP/HUS post-bone marrow transplant.
Chown SR; Goulden N; Cornish JM; Oakhill A; Pamphilon D; Potter MN
Bone Marrow Transplant; 1996 May; 17(5):898-9. PubMed ID: 8733720
[No Abstract] [Full Text] [Related]
36. [Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation].
Salat C; Holler E; Reinhardt B; Kolb HJ; Pihusch R; Neumeister P; Hiller E
Med Klin (Munich); 1994 May; 89(5):245-7. PubMed ID: 8052177
[TBL] [Abstract][Full Text] [Related]
37. Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
Hahn T; Alam AR; Lawrence D; Ford L; Baer MR; Bambach B; Bernstein ZP; Czuczman MS; Silva J; Slack JL; Wetzler M; Becker J; McCarthy PL
Transplantation; 2004 Nov; 78(10):1515-22. PubMed ID: 15599317
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of fragmented red cells after allogeneic bone marrow transplantation.
Kanamori H; Takaishi Y; Takabayashi M; Tanaka M; Yamaji S; Tomita N; Fujimaki K; Fujisawa S; Watanabe S; Matsuzaki M; Ishigatsubo Y
Int J Hematol; 2003 Feb; 77(2):180-4. PubMed ID: 12627855
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy.
Kanamori H; Maruta A; Sasaki S; Yamazaki E; Ueda S; Katoh K; Tamura T; Otsuka-Aoba M; Taguchi J; Harano H; Ogawa K; Mohri H; Okubo T; Matsuzaki M; Watanabe S; Koharazawa H; Fujita H; Kodama F
Bone Marrow Transplant; 1998 Apr; 21(7):705-9. PubMed ID: 9578311
[TBL] [Abstract][Full Text] [Related]
40. Heparin cofactor II as a predictor of thrombotic microangiopathy after bone marrow transplantation.
Takatsuka H; Nakajima T; Nomura K; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H
Hematology; 2006 Apr; 11(2):101-3. PubMed ID: 16753849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
